Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
17%
Ph phase_2
6
50%
Ph early_phase_1
3
25%
Ph phase_1
1
8%

Phase Distribution

4

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
3(25.0%)
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
6(50.0%)
Phase 4Post-market surveillance
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed4
Enrolling by invitation1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (25.0%)
Phase 11 (8.3%)
Phase 26 (50.0%)
Phase 42 (16.7%)

Trials by Status

unknown542%
enrolling_by_invitation18%
withdrawn18%
completed433%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12